RECENT NEWS

Roche has received the CE mark for its Elecsys Dengue Ag test – a high-throughput, fully automated immunoassay to be used as an aid in the diagnosis of an acute dengue virus infection.

Primerdesign (part of the Novacyt Group), a company focussed on the design, manufacture, validation and supply of real-time PCR kits and reagents, has signed a distribution agreement with Scientific Laboratory Supplies (SLS).

EazeBio, a biotechnology company focused on developing scalable, patient-centric solutions, has announced a strategic partnership with the University of California, Santa Cruz (UC Santa Cruz) to co-develop an innovative cortisol biosensor for stress and metabolic health testing.

Lab Innovations, the UK’s biggest trade show event for the laboratory industry, has published a new report examining how artificial intelligence (AI) is being applied in UK laboratories.

Grundium, a specialist in digital imaging for pathology, and Washington University, St. Louis (WashU), have shown that Grundium’s technology matches the diagnostic accuracy of traditional methods for rapid on-site evaluation while decreasing turnaround times and improving patient care.

A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.

Image management system and workflow platform for digital pathology PathPresenter has announced that its Clinical Viewer has met the requirements of the EU In Vitro Diagnostic Regulation (IVDR 2017/746) and can now bear the CE mark. This certification clears it for clinical use in primary diagnosis in Europe.

Researchers at VIB, a leading Belgian life sciences research institute, will conduct on-site testing of CosmoSort, first spatial biology technology to isolate precise cells and tissue regions, without compromising surrounding tissue.

Chandra Mohan, an international expert and pioneer in lupus research at the University of Houston, reports that urine samples can indicate lupus nephritis in a non-invasive manner, without the need for repeat and painful renal biopsies.

Tickets are now available for ‘The Power to Disrupt Through Diagnostics’ the next POCT Innovators one-day conference, which takes place Monday 15 December at London’s National Army Museum.

NHS England has promised an end to short term thinking with the release of a new planning framework document, which also sets out more detail on shifting more healthcare to community settings.

Life science reagents company ProImmune has opened its new global headquarters building at Oasis Park, Oxford, enabling significant expansion of its operations and capacity to serve its global client base.

Diagnostics firm Biodesix has announced the expansion of its partnership agreement with Bio-Rad Laboratories. Biodesix will conduct the development, clinical validation, and regulatory submissions of in vitro diagnostic (IVD) assays to enable highly sensitive detection of multiple genomic markers focused on oncology applications, using Bio-Rad’s Droplet Digital PCR (ddPCR) technology.

Aiforia Technologies, a leading Finnish provider of deep learning AI solutions for digital pathology, has entered into a local agreement with Siemens Healthineers Finland. The partnership focuses on joint co-marketing and sales efforts, leveraging Siemens Healthineers Finland’s strong regional network and expertise in healthcare technology.

CPI has published the latest reports from its MedTech Accelerator: Rapid Regulatory Support (MARRS) fund programme. Building on previous research, the reports show how stronger collaboration across industry, government, academia, and the NHS can unlock the potential of key UK MedTech sectors and accelerate innovation for the benefit of patients.

Catch up with the October issue of Pathology in Practice, now available to read online.

Bruker has announced FDA clearance for its MALDI Biotyper CA System, marking a significant advancement in clinical microbial identification capabilities.

AnalytiChem UK (formerly Cherwell), cleanroom microbiology solutions expert, has appointed Tom Pickford as Business Development Manager for the Midlands. This is a new role created within the recently renamed company to enhance collaboration and support for both new and existing customers across this central region of the UK.

Sinagapore-based researchers have uncovered a surprising mechanism showing how mosquito saliva can alter the human body’s immune response during chikungunya virus (CHIKV) infection, contributing to the country’s broader efforts to strengthen infectious disease preparedness.

Research from the University of Gothenburg, Sweden, clarifies the complex interaction between gut bacteria and irritable bowel syndrome. Experiments demonstrate that gut bacteria can produce the important substance serotonin. The finding may lead to new future treatments.